HB 2050 Summary

• Repeals and re-enacts Missouri section 195.017 to establish the five schedules of controlled substances under state law, with Schedule I containing substances with high abuse potential and no accepted medical use.

• Adds synthetic cannabinoids to Schedule I, including dexanabinol and specific indole and naphthoyl compounds, while maintaining existing opioid, hallucinogen, depressant, and stimulant classifications.

• Establishes Schedule II through V with varying abuse potential and medical use criteria, including prescription medications like amphetamines, benzodiazepines, and opioids with recognized medical applications.

• Implements tracking requirements for over-the-counter sales of pseudoephedrine and ephedrine products, including electronic logs, age verification (18+), pharmacy counter placement, and monthly reporting to the Department of Health and Senior Services.

• Makes violations of pseudoephedrine and ephedrine sale restrictions a class A misdemeanor, while allowing the Department to grant exemptions for drug products not used in illegal methamphetamine manufacturing.